Breast cancer, side population cells and ABCG2 expression

详细信息	查看全文 | 推荐本文 |

• 作者：K.M. Britton^a ; R. Eyre^b ; I.J. Harvey^a ; K. Stemke-Hale^c ; D. Browell^d ; T.W.J. Lennard^e ; A.P. Meeson^a ; ^f ; ^{annette.meeson@ncl.ac.uk}
• 关键词：Breast cancer ; Drug resistance ; Cancer stem cells ; Side population ; ABCG2
• 刊名：Cancer Letters
• 出版年：2012
• 期刊代码：44_03043835
• 类别：med
• 出版时间：1 October, 2012
• 卷：323
• 期：1
• 页码：97-105
• 文件大小：1084 K

摘要

Recurrent metastatic breast cancer may arise in part due to the presence of drug resistant adult stem cells such as Side Population (SP) cells, whose phenotype has been demonstrated to be due to the expression of ABCG2. We hypothesised that SP may be identified in Fine Needle Aspirates (FNAs) and their presence may be determined by expression of ABCG2 in breast tumours. SP and non-side population cells (NSP) were isolated using dual wavelength flow cytometry combined with Hoechst 33342 dye efflux and analysed for expression of ABCG2 and chemoresistance. FNA samples used in SP analysis were matched with paraffin-embedded tissue which was used in immunohistochemical analysis to assess ABCG2 expression. Results were correlated to the pathobiology of the tumour. MCF7 and MDA-MB-231 cell lines contain SP cells. MCF7 SP have increased expression of ABCG2 and increased resistance to mitoxantrone compared to NSP cells. The presence of SP in FNAs were significantly associated with ER-negative (p = 0.008) and with triple negative breast cancers (p = 0.011) which were also found to have a significant increase in ABCG2 protein expression. ABCG2 transcript was detected in some but not all SP cell populations isolated from FNA samples.